0
0.5
1
1.5
2+
Death/intubation
44%
Improvement
Relative Risk
Fluvoxamine Hoertel et al. LATE TREATMENT
Is late treatment with fluvoxamine beneficial for COVID-19?
Retrospective 7,230 patients in France
Lower death/intubation with fluvoxamine (p=0.000021)
c19early.org
Hoertel et al., Molecular Psychiatry, Aug 2020
Favors fluvoxamine
Favors control